Prediction of Surgical Upstaging Risk of Ductal Carcinoma In Situ Using Machine Learning Models

Use of machine learning models to determine eligibility for the COMET trial identified a larger proportion of women eligible for surveillance compared with current eligibility criteria while maintaining similar upstaging rates.